New findings reported on anti-seizure drug use in real-world and clinical trials

A wide range of studies on the use of anti-seizure medications was presented at the AES 2020 virtual conference, including real-world use and clinical trials.

Researchers from the University of Toledo College of Medicine analyzed the electronic records of a specialist epilepsy center to report comparative efficacy data on the real-world use of levetiracetam, lamotrigine, lacosamide, and topiramate as monotherapy.

Data from 929 patients currently receiving monotherapy showed that:

  • 17.5% were receiving levetiracetam, 11.4% lamotrigine, 3.1% lacosamide, and 3.8% topiramate

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.